| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |